GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Current Ratio

Cognetivity Neurosciences (Cognetivity Neurosciences) Current Ratio : 0.02 (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cognetivity Neurosciences's current ratio for the quarter that ended in Oct. 2023 was 0.02.

Cognetivity Neurosciences has a current ratio of 0.02. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Cognetivity Neurosciences has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Cognetivity Neurosciences's Current Ratio or its related term are showing as below:

CGNSF' s Current Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.58   Max: 16.64
Current: 0.02

During the past 7 years, Cognetivity Neurosciences's highest Current Ratio was 16.64. The lowest was 0.02. And the median was 0.58.

CGNSF's Current Ratio is ranked worse than
99.26% of 678 companies
in the Healthcare Providers & Services industry
Industry Median: 1.37 vs CGNSF: 0.02

Cognetivity Neurosciences Current Ratio Historical Data

The historical data trend for Cognetivity Neurosciences's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Current Ratio Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Current Ratio
Get a 7-Day Free Trial 2.92 0.70 1.82 0.33 0.25

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.25 0.11 0.03 0.02

Competitive Comparison of Cognetivity Neurosciences's Current Ratio

For the Health Information Services subindustry, Cognetivity Neurosciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Current Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Current Ratio falls into.



Cognetivity Neurosciences Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cognetivity Neurosciences's Current Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Current Ratio (A: Jan. 2023 )=Total Current Assets (A: Jan. 2023 )/Total Current Liabilities (A: Jan. 2023 )
=1.98/7.893
=0.25

Cognetivity Neurosciences's Current Ratio for the quarter that ended in Oct. 2023 is calculated as

Current Ratio (Q: Oct. 2023 )=Total Current Assets (Q: Oct. 2023 )/Total Current Liabilities (Q: Oct. 2023 )
=0.221/11.437
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cognetivity Neurosciences Current Ratio Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019